SEI Investments’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-11,747
| Closed | -$473K | – | 3281 |
|
|
2026
Q1 | $473K | Sell |
11,747
-48,544
| -81% | -$1.05M | ﹤0.01% | 2670 |
|
|
2025
Q4 | $1.51M | Sell |
60,291
-94,831
| -61% | -$2.22M | ﹤0.01% | 1995 |
|
|
2025
Q3 | $3.51M | Buy |
155,122
+132,763
| +594% | +$3.1M | ﹤0.01% | 1448 |
|
|
2025
Q2 | $387K | Buy |
+22,359
| New | +$414K | ﹤0.01% | 2295 |
|
|
2024
Q4 | – | Sell |
-30,155
| Closed | -$870K | – | 2727 |
|
|
2024
Q3 | $870K | Sell |
30,155
-4,511
| -13% | -$167K | ﹤0.01% | 1995 |
|
|
2024
Q2 | $1.33M | Sell |
34,666
-5,198
| -13% | -$235K | ﹤0.01% | 1810 |
|
|
2024
Q1 | $2.34M | Buy |
39,864
+14,531
| +57% | +$926K | ﹤0.01% | 1560 |
|
|
2023
Q4 | $1.52M | Sell |
25,333
-7,340
| -22% | -$372K | ﹤0.01% | 1716 |
|
|
2023
Q3 | $1.24M | Sell |
32,673
-32,662
| -50% | -$1.43M | ﹤0.01% | 1813 |
|
|
2023
Q2 | $5.95M | Buy |
65,335
+14,140
| +28% | +$1.22M | 0.01% | 1118 |
|
|
2023
Q1 | $3.38M | Buy |
51,195
+40,399
| +374% | +$2.33M | 0.01% | 1380 |
|
|
2022
Q4 | $558K | Sell |
10,796
-45,125
| -81% | -$2.39M | ﹤0.01% | 1967 |
|
|
2022
Q3 | $3.82M | Buy |
+55,921
| New | +$3.31M | 0.01% | 1217 |
|
|
2021
Q3 | – | Sell |
-19,674
| Closed | -$1.24M | – | 2549 |
|
|
2021
Q2 | $1.24M | Buy |
19,674
+3,406
| +21% | +$176K | ﹤0.01% | 1716 |
|
|
2021
Q1 | $931K | Hold |
16,268
| – | – | ﹤0.01% | 1782 |
|
|
2020
Q4 | $931K | Buy |
+16,268
| New | +$688K | ﹤0.01% | 1722 |
|
|
2020
Q2 | – | Sell |
-7,785
| Closed | -$209K | – | 2377 |
|
|
2020
Q1 | $209K | Buy |
+7,785
| New | +$276K | ﹤0.01% | 2104 |
|
Other funds holding APLS
SEI Investments's APLS Position: Q2 2026 in Review
SEI Investments sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 11,747 shares — an estimated $473K sold.
SEI Investments first reported a position in APLS in Q1 2020 and held it in 17 quarters. The position peaked at $5.95M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- SEI Investments reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- SEI Investments sold 11,747 Apellis Pharmaceuticals shares in Q2 2026, an estimated $473K.
- SEI Investments first reported a position in Apellis Pharmaceuticals in Q1 2020 and held it in 17 quarters.
- SEI Investments's Apellis Pharmaceuticals position peaked at $5.95M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.